Disclosure Of Material Accounting Policy Information [Text Block]

HEMOGENYX PHARMACEUTICALS PLC - Filing #5969073

Concept 2024-01-01 to
2024-12-31
Disclosure of material accounting policy information [text block]
Description of accounting policy for borrowings [text block]
Interest Bearing Loans and Borrowings
Description of accounting policy for deferred income tax [text block]
Deferred tax
Description of accounting policy for determining components of cash and cash equivalents [text block]
Cash
Description of accounting policy for financial liabilities [text block]
Description of accounting policy for foreign currency translation [text block]
Foreign currencies
Description of accounting policy for functional currency [text block]
Functional and presentation currency
Description of accounting policy for impairment of financial assets [text block]
Impairment of Financial Assets
Description of accounting policy for impairment of non-financial assets [text block]
Impairment of non-financial assets
Description of accounting policy for income tax [text block]
Taxation
Description of accounting policy for leases [text block]
Leases
Description of accounting policy for intangible assets and goodwill [text block]
Intangibles
Description of accounting policy for property, plant and equipment [text block]
Fixed assets
Description of accounting policy for research and development expense [text block]
Research and development expenditure
Description of accounting policy for segment reporting [text block]
Segmental reporting
Description of accounting policy for share-based payment transactions [text block]
Share-based payments
Description of accounting policy for trade and other payables [text block]
Trade and other receivables and payables

Talk to a Data Expert

Have a question? We'll get back to you promptly.